Sanofi: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
k RaymondSutanto memindahkan halaman Sanofi-Aventis ke Sanofi: berganti nama
Tidak ada ringkasan suntingan
Baris 1:
{{Infobox company
{{Infobox_Company |
| name company_name = Sanofi-Aventis| S.A.
| logo company_logo = [[BerkasFile:Sanofi Aventis.pngsvg|200px150px]] |
| type = [[Société Anonyme]]
company_type = Publik ([[Euronext]] [http://www.euronext.com/trader/summarizedmarket/0,5372,1732_6834,00.html?selectedMep=1&idInstrument=20812&isinCode=FR0000120578 SAN], [[New York Stock Exchange|NYSE]], [[London Stock Exchange|LSE]] dan [[Frankfurt Stock Exchange|FWB]])|
| traded_as = {{Euronext|SAN}}, {{NYSE|SNY}}, {{LSE|0I42}}, {{FWB|SNW}}
company_slogan = Because health matters. ([[Bahasa Perancis|Perancis]]: ''L'essentiel c'est la santé.'')|
| foundation = [[20 Agustus]] [[2004]] ''oleh(akuisisi) merger''sebagai |Sanofi Aventis<br />6 May 2011 sebagai Sanofi
| location = 54, rue La Boétie, [[8th arrondissement of Paris|8th arrondissement]], [[PerancisParis]], [[France]]|
| key_people = [[Chris Viehbacher]] <small>([[chief executive officer|CEO]])</small>, [[Serge Weinberg]] <small>([[Chairman]])</small>, [[Jean-François Dehecq]] ''Chairman''{{br}}<small>([[GérardOriginal Le FurFounder]])</small> ''CEO''|
| industry = [[FarmasiIndustri obat-obatan]]|
| products = [[Prescription drug|Prescription]] and [[over-the-counter drug]]s for [[trombosis]], [[cardiovascular disease]], [[diabetes]], kelainan [[sistem saraf pusat]], [[onkologi]] and [[internal medicine]], [[vaksin]] ([[#Products|list...]])
num_employees = 96,439 (2004) |
| revenue = [[Euro|€]]32.95 milyar (2013)<ref name="AR2013">{{cite web |url=http://en.sanofi.com/Images/35795_20-F_2013.pdf |title=Annual Report 2013 |accessdate=13 April 2014 |publisher=Sanofi-Aventis}}</ref>
products = [[Cardiovascular]], [[central nervous system]], [[oncology]], dan [[internal medicine]] formulations.{{br}}Flagship products:{{br}}[[Fexofenadine|Allegra®]] (allergy){{br}}[[Enoxaparin|Lovenox®]] (deep vein thrombosis){{br}}[[Clopidogrel|Plavix®]] (thrombosis){{br}}[[Irbesartan|Avapro®]] (hypertension){{br}}[[Zolpidem|Ambien®]] (insomnia){{br}}[[Oxaliplatin|Eloxatin®]] (chemotherapy) {{br}} [[Telithromycin|Ketek®]] ([[ketolide]] [[antibiotic]])|
| operating_income = €5.11 milyar (2013)<ref name="AR2013" />
revenue = [[Berkas:green up.png]]27.311 miliar [[euro]]s ([[2005]]){{br}}&nbsp;&nbsp;&nbsp;($34.013 billion [[Dolar Amerika Serikat|USD]])|
| net_income = €3.72 milyar (2013)<ref name="AR2013" />
homepage = [http://en.sanofi-aventis.com/ en.sanofi-aventis.com]|
| assets = €96.07 milyar (2013)<ref name="AR2013" />
| equity = €56.89 milyar (2013)<ref name="AR2013" />
| num_employees = 112.128 (2013)<ref name="AR2013" />
| subsid = [[Sanofi Pasteur]]<br>[[Genzyme]]<br>[[Shantha Biotechnics]]<br>[[Chattem]]<br>[[Zentiva]]<br>[[Medley]]<br>Nichi-Iko<br>Merial
| homepage = [{{URL|http://enwww.sanofi-aventis.com/ en.sanofi-aventis.com]|}}
| intl = yes
}}
 
'''Sanofi-Aventis S.A.''' ({{Euronext|SAN}}, {{NYSE|SNY}}), merupakan satu dari lima perusahaan [[farmasi]] terbesar di dunia, setelah [[Pfizer]], [[Bristol-Myers]], [[Squibb]], [[Novarits]], dan [[GlaxoSmithKline]]. Bermarkas di [[Paris]]. Perusahaan ini menghasilkan berbagai macam farmasi. Didirikan pada tahun [[2004]] setelah [[Sanofi-Synthélabo]] gabung dengan [[Aventis]].
 
== Lihat pula ==
Baris 24 ⟶ 30:
* [http://www.sanofipasteur.com sanofi pasteur - The vaccines business of sanofi-aventis Group]
 
{{Euro Stoxx 50 Companies}}
 
{{perusahaan-stub}}
 
[[Kategori:Perusahaan Perancis]]
[[Kategori:Perusahaan farmasi]]
[[Kategori:Perusahaan yang didirikan tahun 2004]]